Microglia polarization, gene-environment interactions and wnt/β-catenin signaling: Emerging roles of glia-neuron and glia-stem/neuroprogenitor crosstalk for dopaminergic neurorestoration in aged Parkinsonian brain

Frontiers in Aging Neuroscience

Volumn 10, Issue , 2018, Pages

  L'Episcopo, Francesca ^a   Tirolo, Cataldo ^a   Serapide, Maria F ^b   Caniglia, Salvatore ^a   Testa, Nunzio ^a   Leggio, Loredana ^b   Vivarelli, Silvia ^b   Iraci, Nunzio ^b   Pluchino, Stefano ^c   Marchetti, Bianca ^a,b  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aging; Dopaminergic Neurons; Neurodegeneration; Neurogenesis; Neuroinflammation; Neuroprotection; Parkinson's Disease; Wnt b catenin Signaling

Indexed keywords

BETA CATENIN; WNT PROTEIN;

AGING; ASTROCYTE; CAUSAL ATTRIBUTION; CELL INTERACTION; DOPAMINERGIC SYSTEM; GENE MUTATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MICROGLIA; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PHENOTYPE; POLARIZATION; REVIEW; WNT SIGNALING;

EID: 85042351747     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2018.00012     Document Type: Review

References (231)

1. Abou-Sleiman, P. M., Muqit, M. M., andWood, N.W. (2006). Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7, 207-219. doi: 10.1038/nrn1868
2. Adachi, K., Mirzadeh, Z., Sakaguchi, M., Yamashita, T., Nikolcheva, T., Gotoh, Y., et al. (2007). b-catenin signaling promotesproliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 25, 2827-2836. doi: 10.1634/stemcells.200 7-0177
3. Alvarez-Buylla, A., García-Verdugo, J.M., and Tramontin, A. D. (2001). A unified hypothesis on the lineage of neural stem cells. Nat. Rev. Neurosci. 2, 287-293. doi: 10.1038/35067582
4. Angers, S., and Moon, R. T. (2009). Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10, 468-477. doi: 10.1038/nrm2717
5. Arenas, E. (2014). Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease. J. Mol. Cell Biol. 6, 42-53. doi: 10.1093/jmcb/mju001
6. Baba, Y., Kuroiwa, A., Uitti, R., Wszolek, J., and Yamada, T. (2005). Alterations of T-lymphocyte populations in Parkinson's disease. Parkinson. Relat. Disord. 11, 493-498. doi: 10.1016/j.parkreldis.2005.07.005
7. Baker, S. A., Baker, K. A., and Hagg, T. (2004). Dopaminergic nigrostriatal projections regulate neural precursor cell proliferation in the adult mouse subventricular zone. Eur. J. Neurosci. 20, 575-579. doi: 10.1111/j.1460-9568. 2004.03486.x
8. Barcia, C., Ros, C. M., Ros-Bernal, F., Gómez, A., Annese, V., Carrillo-de Sauvage, M. A., et al. (2013). Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques. J. Neuroimmunol. 261, 60-66. doi: 10.1016/j.jneuroim.2013.05.001
9. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04) 00045-5
10. Bélanger,M., andMagistretti, P. J. (2009). The role of astroglia in neuroprotection. Dialog. Clin. Neurosci. 11, 281-295.
11. Bendor, J. T., Logan, T. P., and Edwards, R. H. (2013). The function of a-synuclein. Neuron 79, 1044-1066. doi: 10.1016/j.neuron.2013.09.004
12. Berwick, D. C., and Harvey, K. (2012a). LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6. Hum.Mol. Genet. 21, 4966-4979. doi: 10.1093/hmg/dds342
13. Berwick, D. C., and Harvey, K. (2012b). The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. Trans. 40, 1123-1128. doi: 10.1042/BST20120122
14. Berwick, D. C., and Harvey, K. (2014). The regulation and deregulation of Wnt signalling by PARK genes in health and disease. J. Mol. Cell Biol. 6, 3-12. doi: 10.1093/jmcb/mjt037
15. Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon-Abell, J., Grannò, S., et al. (2017). Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of b-catenin signaling. Mol. Neurodegener. 12:9. doi: 10.1186/s13024-017-0153-4
16. Beurel, E. (2011). Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front.Mol. Neurosci. 4:18. doi: 10.3389/fnmol.2011.00018
17. Beurel, E., Michalek, S. M., and Jope, R. S. (2010). Innate and adaptive immune responses regulated by glycogen synthase kinase-3(GSK3). Trends Immunol. 31, 24-31. doi: 10.1016/j.it.2009.09.007
18. Bian, S., and Sun, T. (2011). Functions of noncoding RNAs in neural development and neurological diseases. Mol. Neurobiol. 44, 359-373. doi: 10.1007/s12035-011-8211-3
19. Bilic, J., Huang, Y.-L., Davidson, G., Zimmermann, T., Cruciat, C.-M., Bienz, M., et al. (2007). Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316, 1619-1622. doi: 10.1126/science.1137065
20. Blandini, F., and Armentero, M. T. (2012). Animal models of Parkinson's disease. FEBS J. 279, 1156-1166. doi: 10.1111/j.1742-4658.2012.08491.x
21. Boger, H. A., Granholm, A. C.,McGinty, J. F., andMiddaugh, L. D. (2010). A dualhit animal model for age-related parkinsonism. Prog. Neurobiol. 90, 217-229. doi: 10.1016/j.pneurobio.2009.10.013
22. Borta, A., and Höglinger, G. U. (2007). Dopamine and adult neurogenesis. J. Neurochem. 100, 587-595. doi: 10.1111/j.1471-4159.2006.04241.x
23. Bové, J., and Perier, C. (2012). Neurotoxin-based models of Parkinson's disease. Neuroscience 211, 51-76. doi: 10.1016/j.neuroscience.2011.10.057
24. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E., and Lopez-Rios, J. (2008). Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci. 121, 737-746. doi: 10.1242/jcs.026096
25. Brochard, V., Combadière, B., Pigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., et al. (2009). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119, 182-192. doi: 10.1172/JCI36470
26. Cadigan, K. M., and Waterman, M. L. (2012). TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb. Perspect. Biol. 4:a007906. doi: 10.1101/cshperspect.a007906
27. Cannon, J. R., and Greenamyre, J. T. (2013). Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models. Neurobiol. Dis. 57, 38-46. doi: 10.1016/j.nbd.2012.06.025
28. Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., and Luo, J. (2004). Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxy dopamine-induced neuronal death. FASEB J. 18, 1162-1164. doi: 10.1096/fj.04-1551fje
29. Chen, H., Jacobs, E. J., Schwarzschild,M. A.,McCullough,M. L., Calle, E. E., Thun, M. J., et al. (2005). Nonsteroidal anti-inflammatory drug use and the risk for Parkinson's disease. Ann. Neurol. 58, 963-967. doi: 10.1002/ana.20682
30. Chen, H., Zhang, S. M., Herman, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., et al. (2003). Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease. Arch. Neurol. 60, 1059-1064. doi: 10.1001/archneur.60. 8.1059
31. Chen, P. C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., et al. (2009). Nrf2-mediated neuroprotection in theMPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc. Natl. Acad. Sci. U.S.A. 106, 2933-2938. doi: 10.1073/pnas.0813361106
32. Chen, Y., Qi, B., Xu,W.,Ma, B., Li, L., Chen, Q., et al. (2015). Clinical correlation of peripheral CD4+-ccell sub-sets, their imbalance and Parkinson's disease. Mol. Med. Rep. 12, 6105-6111.
33. Chong, Z. Z., and Maiese, K. (2007). Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signalling pathways. Cell Signal. 19, 1150-1162. doi: 10.1016/j.cellsig.2006.12.009
34. Chong, Z. Z., Shang, Y. C., Hou, J., and Maiese, K. (2010). Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. Oxidat. Med Cell. Long. 3, 153-165. doi: 10.4161/oxim.3.2. 11758
35. Ciani, L., and Salinas, P. C. (2005). WNTs in the vertebrate nervous system: From patterning to neuronal connectivity. Nat. Rev. Neurosi. 6, 351-362. doi: 10.1038/nrn1665
36. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480. doi: 10.1016/j.cell.2006.10.018
37. Clevers, H., andNusse, R. (2012).Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205. doi: 10.1016/j.cell.2012.05.012
38. Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., et al. (2013). Triggering of inflammasome by aggregated a-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8:e55375. doi: 10.1371/journal.pone.0055375
39. Collier, T. J., Lipton, J., Daley, B. F., Palfi, S., Chu, Y., Sortwell, C., et al. (2007). Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol. Dis. 26, 56-65. doi: 10.1016/j.nbd.2006.11.013
40. Collins, L. M., Toulouse, A., Connor, T. J., and Nolan, Y. M. (2012). Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Neuropharmacology 62, 2154-2168. doi: 10.1016/j.neuropharm.2012.01.028
41. Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., and Perry, V. H. (2005). Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275-9284. doi: 10.1523/JNEUROSCI.2614-05.2005
42. Curtis, M. A., Faull, R. L. M., and Eriksson, P. S. (2007). The effect of neurodegenerative diseases on the subventricular zone. Nat. Rev. Neurosci. 8, 712-723. doi: 10.1038/nrn2216
43. Cusimano, M., Biziato, D., Brambilla, E., Donegà, M., Alfaro-Cervello, C., Snider, S., et al. (2012). Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 135, 447-460. doi: 10.1093/brain/awr339
44. Damani, M. R., Zhao, L., Fontainhas, A. M., Amaral, J., and Fariss, R. N. (2010). Age-related alterations in the dynamic behavior of microglia. Aging Cell 10, 263-276. doi: 10.1111/j.1474-9726.2010.00660.x
45. de la Fuente-Fernández, R., Schulzer,M., Kuramoto, L., Cragg, J., Ramachandiran, N., Au,W. L., et al. (2011). Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann. Neurol. 69, 803-810. doi: 10.1002/ana.22284
46. Deleidi, M., Hallett, P. J., Koprich, J. B., Chung, C. Y., and Isacson, O. (2010). The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. J. Neurosci. 30, 16091-16101. doi: 10.1523/JNEUROSCI.2400-10.2010
47. Deng, H.,Gao, K., and Jankovic, J. (2013). The VPS35 gene and Parkinson's disease. Mov Disord. 28, 569-575. doi: 10.1002/mds.25430
48. Depboylu, C., Stricker, S., Ghobril, J. P., Oertel, W. H., Priller, J., and Höglinger, G. U. (2012). Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp. Neurol. 238, 183-191. doi: 10.1016/j.expneurol.2012.08.020
49. Di Monte, D. A., and Langston, J. W. (1995). "Idiopathic and 1-methyl-4phenyl- 1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism," in Neuroglia, Chapter 65, eds H. Kettenmann and B. R. Ransom (New York, NY: Oxford University Press), 997-989.
50. Di Monte, D. A., Lavasani, M., and Manning-Bog, A. B. (2002). Environmental factors in Parkinson's disease. NeuroToxicology 23, 487-502. doi: 10.1016/S0161-813X(02)00099-2
51. Duka, T., Duka, V., Joyce, J. N., Joyce, J. N., and Sidhu, A. (2009). a-Synuclein contributes to GSK-3b- catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J. 23, 2820-2830. doi: 10.1096/fj.08-120410
52. Dzamko, N., Geczy, C. L., and Halliday, G. M. (2015). Inflammation is genetically implicated in Parkinson's disease. Neuroscience 302, 89-102. doi: 10.1016/j.neuroscience.2014.10.028
53. Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., et al. (2017). Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 133, 303-319. doi: 10.1007/s00401-016-1648-8
54. Ehninger, D., Wang, L. P., Klempin, F., Römer, B., Kettenmann, H., and Kempermann, G. (2011). Enriched environment and physical activity reduce microglia and influence the fate of NG2 cells in the amygdala of adult mice. Cell Tissue Res. 345, 69-86. doi: 10.1007/s00441-011-1200-z
55. Ekdahl, C. T., Claasen, J. H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003). Inflammation is detrimental for neurogenesis in the adult brain. Proc. Natl. Acad. Sci. U.S.A. 100, 13632-13637. doi: 10.1073/pnas.2234031100
56. Ekdahl, C. T., Kokaia, Z., and Lindvall, O. (2009). Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158, 1021-1029. doi: 10.1016/j.neuroscience.2008.06.052
57. Ekdhal, C. T. (2012).Microglial activation: tuning and pruning adult neurogenesis. Front. Pharmacol. 3:41. doi: 10.3389/fphar.2012.00041
58. Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., et al. (2014). Neurogenesis in the striatum of the adult human brain. Cell 156, 1072-1083. doi: 10.1016/j.cell.2014.01.044
59. Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., and Di Giovanni, G. (2007). Non-steroidal anti-inflammatory drigs in parkinson's disease. Exp. Neurol. 205, 295-312. doi: 10.1002/mds.20856
60. Ferreira, M., and Massano, J. (2016). An updated review of Parkinson's disease genetics and clinico-pathological correlations. Acta Neurol. Scand. 135, 273-284. doi: 10.1111/ane.12616
61. Fiorucci, S., and Antonelli, E. (2006). NO-NSAIDs: from inflammatory mediators to clinical readouts. Inflam. Allergy Drug Targets 5, 121-131. doi: 10.2174/187152806776383161
62. Flanary, B. (2005). The role of microglial cellular senescence in the aging and Alzheimer diseased brain. Rejuvenat. Res. 8, 82-85. doi: 10.1089/rej.2005.8.82
63. Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D., and Streit, W. J. (2007). Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 10, 61-74. doi: 10.1089/rej.2006.9096
64. Frank-Cannon, T. C., Tran, T., Ruhn, K. A., Martinez, T. N., Hong, J., Marvin, M., et al. (2008). Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci. 28, 10825-10834. doi: 10.1523/JNEUROSCI.3001-08.2008
65. Freundlieb, N., François, C., Tandé, D., Ortel, W. H., Hirsh, E. C., and Höglinger, G. U. (2006). Dopaminergic subtantia nigra neurons project topographically organized to the subventricular zone and stimulateprecursor cell proliferation in aged primates. J. Neurosci. 26, 2321-2325. doi: 10.1523/JNEUROSCI.4859-05.2006
66. Galli, S., Lopes, D. M., Ammari, R., Kopra, J., Millar, S. E., Gibb, A., et al. (2014). Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice. Nat. Commun. 5:4992. doi: 10.1038/ncomms5992
67. Gao, H. M., and Hong, J. S. (2008). Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29, 357-365. doi: 10.1016/j.it.2008.05.002
68. Gao, H. M., and Hong, J. S. (2011). Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog. Neurobiol. 94, 1-19. doi: 10.1016/j.pneurobio.2011.03.005
69. Gao, H. M., Zhang, F., Zhou, H., Kam, W., Wilson, B., and Hong, J. S. (2011). Neuroinflammation and a-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ. Health Perspect. 119, 807-814. doi: 10.1289/ehp.1003013
70. Gao, J., Nalls, M. A., Shi, M., Joubert, B. R., Hernandez, D. G., Huang, X., et al. (2012). An exploratory analysis on gene-environment interactions for Parkinson disease. Neurobiol. Aging 33, 2528.e1-6. doi: 10.1016/j.neurobiolaging.2012.06.007
71. Gennuso, F., Fernetti, C., Tirolo, C., Testa, N., L'Episcopo F., Caniglia, S., et al. (2004). Bilirubin protects astrocytes from its own toxicity inducing up-regulation and translocation of multigrug resistanceassociated protein 1 (Mrp 1). Proc. Natl. Acad. Sci. U.S.A. 101, 2470-2475. doi: 10.1073/pnas.0308452100
72. Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., et al. (2006). In vivo imaging of microglial activation with [11C](R)- PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 21, 404-412. doi: 10.1016/j.nbd.2005.08.002
73. Gillardon, F., Schmid, R., and Draheim, H. (2012). Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience 208, 41-48. doi: 10.1016/j.neuroscience.2012.02.001
74. Glinka, A., Dolde, C., Kirsch, N., Huang, Y. L., Kazanskaya, O., Ingelfinger, D., et al. (2011). LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep. 12, 1055-1061. doi: 10.1038/embor.2011.175
75. Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., et al. (2005). Exaggerated neuroinflammation and sickness behaviour in aged mice after activation of the peripheral innate immune system. FASEB J. 19, 1329-1331. doi: 10.1096/fj.05-3776fje
76. Gordon, M. D., and Nusse, R. (2006). Wnt signaling: multiple pathways, multiple receptors and multiple transcription factors. J. Biol. Chem. 281, 22429-22433. doi: 10.1074/jbc.R600015200
77. Grimes, C. A., and Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391-426. doi: 10.1016/S0301-0082(01)00011-9
78. Halleskog, C., Dijksterhuis, J. P., Kilander, M. B., Becerril-Ortega, J., Villaescusa, J. C., Lindgren, E., et al. (2012). Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflammation 30:111. doi: 10.1186/1742-2094- 9-111
79. Halleskog, C., Mulder, J., Dahlström, J., Mackie, K., Hortobágyi, T., Tanila, H., et al. (2011). WNT signaling in activated microglia is proinflammatory. Glia 59, 119-131. doi: 10.1002/glia.21081
80. Halleskog, C., and Schulte, G. (2013a). WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia. Neurochem. 125, 803-808. doi: 10.1111/jnc.12250
81. Halleskog, C., and Schulte, G. (2013b). Pertussis toxin-sensitive heterotrimeric G(ai/o) proteins mediate WNT/b-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A. Cell Signal. 25, 822-828. doi: 10.1016/j.cellsig.2012.12.006
82. Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., et al. (2010). Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 42, 781-785. doi: 10.1038/ng.642
83. Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., et al. (2013). MHCII is required for a-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 33, 9592-9600. doi: 10.1523/JNEUROSCI.5610-12.2013
84. Harvey, K., and Marchetti, B. (2014). Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration. J. Mol. Cell Biol. 6, 1-2. doi: 10.1093/jmcb/mju002
85. He, P., and Shen, Y. (2009). Interruption of b-catenin signaling reduces neurogenesis in Alzheimer's disease. J. Neurosci. 29, 6545-6557. doi: 10.1523/JNEUROSCI.0421-09.2009
86. He, Q.,Wang, Q., Yuan, C., andWang, T. (2017). Downregulation of miR-7116-5p in microglia by MPP(+) sensitizes TNF-a production to induce dopaminergic neuron damage. Glia 65, 1251-1263. doi: 10.1002/glia.23153
87. Henry, C. J., Huang, Y., Wynne, A., and Godbout, J. P. (2009). Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1b and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23, 309-317. doi: 10.1016/j.bbi.2008.09.002
88. Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39, 156-161. doi: 10.1093/ageing/afp223
89. Hirsch, E. C., and Hunot, S. (2009). Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8, 382-397. doi: 10.1016/S1474-4422(09)70062-6
90. Hirsch, E. C., Jenner, P., and Przedborski, S. (2013). Pathogenesis of Parkinson's disease. Mov. Disord. 28, 24-30. doi: 10.1002/mds.25032
91. Höglinger, G. U., Barker, R. A., Hagg, T., Arias-Carrión, O., Caldwell, M. A., and Hirsch, E. C. (2012). Quantitative evaluation of the human subventricular zone. Brain. 135:e221, 1-4. doi: 10.1093/brain/aws087
92. Höglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., et al. (2004). Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci. 7, 726-735. doi: 10.1038/nn1265
93. Hornykiewicz, O. (1993). Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol. 60, 140-147.
94. Hu, X., Zhang, D., Pang, H., Caudle, W. M., Li, Y., Gao, H., et al. (2008). Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J. Immunol. 181, 7194-7204. doi: 10.4049/jimmunol.181. 10.7194
95. Inestrosa, N. C., and Arenas, E. (2010). Emerging role ofWnts in the adult nervous system. Nat. Rev. Neurosci. 11, 77-86. doi: 10.1038/nrn2755
96. International Parkinson Disease Genomics Consortium, Nalls, M. A., Plagnol, V., Hernandez, D. G., Sharma, M., Sheerin, U. M., et al. (2011). Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641-649. doi: 10. 1016/S0140-6736(10)62345-8
97. Jakubs, K., Bonde, S., Iosif, R. E., Ekdahl, C. T., Kokaia, Z., Kopkaia, M., et al. (2008). Inflammation regulates functional integration of neurons born in adult brain. J. Neurosci. 28, 12477-12488. doi: 10.1523/JNEUROSCI.3240-08.2008
98. Joksimovic, M., and Awatramani, R. (2014). Wnt/b-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis. J.Mol. Cell Biol. 6, 27-33. doi: 10.1093/jmcb/mjt043
99. Jope, R. S., Yuskaitis, C. J., and Beurel, E. (2007). Glycogen synthase kinase- 3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 32, 577-595. doi: 10.1007/s11064-006-9128-5
100. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W., Im, J. Y., and Mouradian, M. M. (2009). Repression of alpha-synuclein expression and toxicity by microRNA- 7. Proc. Natl. Acad. Sci. U.S.A. 106, 13052-13057. doi: 10.1073/pnas.09062 77106
101. Kalani, M. Y., Cheshir, S. H., Cord, B. J., Bababeygy, S. R., Vogel, H., Weissman, I. L., et al. (2008). Wnt-mediated self-renewal of neural stem/progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 105, 16970-16975. doi: 10.1073/pnas.08086 16105
102. Kannarkat, G. T., Boss, J. M., and Tansey, M. G. (2013). The role of innate and adaptive immunity in Parkinson's disease. J. Parkins. Dis. 3, 493-514. doi: 10.3233/JPD-130250
103. Kazanis, I. (2009). The subependymal zone neurogenic niche: a beating heart in the centre of the brain: how plastic is adult neurogenesis?Opportunities for therapy and questions to be addressed. Brain 132, 2909-2921. doi: 10.1093/brain/awp237
104. Kilander, M. B., Halleskog, C., and Schulte, G. (2011). Recombinant WNTs differentially activate b-catenin-dependent and -independent signalling in mouse microglia-like cells. Acta Physiol. 203, 363-372. doi: 10.1111/j.1748-1716.2011.02324.x
105. Kim, B., Yang, M. S., Choi, D., Kim, J. H., Kim, H. S., Seol, W., et al. (2012). Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLoS ONE 7:e34693. doi: 10.1371/journal.pone.0034693
106. Kim, W. Y., and Snider, W. D. (2011). Functions of GSK-3 signaling in development of the nervous system. Front. Mol. Neurosci. 4:44. doi: 10.3389/fnmol.2011.00044
107. Kim,W. Y.,Wang, X.,Wu, Y., Doble, B.W., Patel, S.,Woodgett, J. R., et al. (2009). GSK-3 is a master regulator of neural progenitor homeostasis. Nat. Neurosci. 12, 1390-1397. doi: 10.1038/nn.2408
108. King, M. K., Pardo, M., Cheng, Y., Downey, K., Jope, R. S., and Beurel, E. (2013). Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments. Pharmacol. Ther. 141, 1-12. doi: 10.1016/j.pharmthera.2013.07.010
109. Kokaia, Z., Martino, G., Schwartz, M., and Lindvall, O. (2012). Cross-talk between neural stemcells and immune cells: the key to better brain repair? Nat. Neurosci. 15, 1078-1087. doi: 10.1038/nn.3163
110. Koprich, J. B., Reske-Nielsen, C., Mithal, P., and Isacson, O. (2008). Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J. Neuroinflammation 5:8. doi: 10.1186/1742-2094-5-8
111. Kreutzberg, G. W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318. doi: 10.1016/0166-2236(96)10049-7
112. Kuter, K., Olech, L., and Glowacka, U. (2017). Prolonged dysfunction of astrocytes and activation of microglia accelerate degeneration of dopaminergic neurons in the rat substantia nigra and block compensation of early motor dysfunction induced by 6-OHDA. Mol. Neurobiol. 1-18. doi: 10.1007/s12035-017-0529-z. [Epub ahead of print].
113. Kuwabara, T., Hsieh, J., Muotri, A., Yeo, G., Warashina, M., Lie, D. C., et al. (2009). Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat. Neurosci. 12, 1097-1105. doi: 10.1038/nn.2360
114. Langston, J. W. (2006). The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann. Neurol. 59, 591-596. doi: 10.1002/ana.20834
115. Langston, J. W., Forno, L. S., Tetrud, J., Reevers, A. G., Kaplan, J. A., and Karluk, D. (1999). Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598-605.
116. Langston, J.W., Sastry, S., Chan, P., Forno, L. S., Bolin, L.M., and DiMonte, D. A. (1998). Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Exp. Neurol. 154, 684-690. doi: 10.1006/exnr.1998.6975
117. Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rabano, A., Kirik, D., et al. (2012). a-Synuclein expression and Nrf2-deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in earlystage Parkinson's disease. Hum. Mol. Genet. 21, 3173-3192. doi: 10.1093/hmg/ dds143
118. Latourelle, J. C., Dimitriu, A., Hadzi, T. C., Beach, T. G., Mayers, R. H., and Lewis, P. (2012). Evaluation of Parkinson disease risk variants as expression-QTLs. PLoS ONE. 7:e46199. doi: 10.1371/journal.pone.0046199
119. Lee, H., James, W. S., and Cowley, S. A. (2017). LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease. Biochem. Soc. Trans. 45, 131-139. doi: 10.1042/BST20160262
120. Lema Tomé, C. M., Tyson, T., Rey, L. N., Grathwohl, S., Britschgi, M., and Brundin, P. (2012). Inflammation and alpha synuclein's prion-like behavior in Parkinson's disease-is there a link? Mol. Neurobiol. 29, 826-848. doi: 10.1007/s12035-012-8267-8
121. Lennington, J. B., Pope, S., Goodheart, A. E., Drozdowicz, L., Daniels, S. B., Salamone, J. D., et al. (2011). Midbrain dopamine neurons associated with reward processing innervate the neurogenic subventricular zone. J. Neurosci. 31, 13078-13087. doi: 10.1523/JNEUROSCI.1197-11.2011
122. L'Episcopo, F.,Drouin-Ouellet, J., Tirolo, C., Testa,N., Caniglia, S., Serapide,M.-F., et al. (2016). GSK-3b-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions. Cell Death Dis. 7:e2206. doi: 10.1038/cddis.2016.104
123. L'Episcopo, F., Serapide, M. F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., et al. (2011b). A Wnt1 regulated Frizzled-1/b-catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol. Neurodeg. 13, 6-49. doi: 10.1186/1750-1326-6-49
124. L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Serra, P. A., Impagnatiello, F., et al. (2010b). Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neuroinflam. 7:83. doi: 10.1186/1742-2094-7-83
125. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., and Marchetti, B. (2010a). Glia as a turning point in the therapeutic strategy of Parkinson's disease. CNS Neurol. Disord. 9, 349-372. doi: 10.2174/187152710791292639
126. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Cossetti, C., et al. (2011a). Reactive astrocytes andWnt/b-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis. 41, 508-527. doi: 10.1016/j.nbd.2010.10.023
127. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Impagnatiello, F., et al. (2011c). Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice. Rejuvenation Res. 14, 411-424. doi: 10.1089/rej.2010.1134
128. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Serapide, M. F., et al. (2012). Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves crosstalk between inflammatory and Wnt/b-catenin signaling pathways: functional consequences for neuroprotection and repair. J. Neurosci. 32, 2062-2085. doi: 10.1523/JNEUROSCI.5259-11.2012
129. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Impagnatiello, F., et al. (2013). Aging-induced Nrf2-ARE pathway disruption in the subventricular zone (SVZ) drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/b-catenin dysregulation. J. Neurosci. 33, 1462-1485. doi: 10.1523/JNEUROSCI.3206-12.2013
130. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Serapide, M. F., Pluchino, S., et al. (2014a).Wnt/b-catenin signaling is required to rescue midbrain dopaminergic progenitors and restore nigrostriatal plasticity in ageing mouse model of Parkinson's disease. Stem Cells 32, 2147-2163. doi: 10.1002/stem.1708
131. L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Morale, M. C., Serapide, M. F., et al. (2014b). Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/ repair in Parkinson's disease. J. Mol. Cell Biol. 6, 13-26. doi: 10.1093/jmcb/mjt053
132. Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481-487. doi: 10.1038/nature21029
133. Lim, D. A., and Alvarez-Buylla, A. (1999). Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 96, 7526-7531. doi: 10.1073/pnas.96.13.7526
134. Liu, G., and Abraham, E. (2013). MicroRNAs in immune response and macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 33, 170-177. doi: 10.1161/ATVBAHA.112.300068
135. Louafi, F., Martinez-Nunez, R. T., and Sanchez-Elsner, T. (2010). MicroRNA- 155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-beta. J. Biol. Chem. 285, 41328-41336. doi: 10.1074/jbc.M110.146852
136. Maiese, K., Faqi, L., Chong, Z. Z., and Shang, Y. C. (2008). The Wnt signalling pathway: aging gracefully as a protectionist? Pharmacol. Ther. 118, 58-81. doi: 10.1016/j.pharmthera.2008.01.004
137. Marchetti, B., and Abbracchio,M. P. (2005). To be or not to be (inflammed) is that the question in anti-inflammatory drug therapy of neurodegenerative diseases? Trends Pharmacol. Sci. 26, 517-525. doi: 10.1016/j.tips.2005.08.007
138. Marchetti, B., and Pluchino, S. (2013). Wnt your brain be inflamed? Yes, it Wnt! Trends Mol. Med. 19, 144-156. doi: 10.1016/j.molmed.2012.12.001
139. Marchetti, B., Kettenmann, H., and Streit, W. J. (2005a). Glia-neuron crosstalk in neuroinflammation, neurodegeneration and neuroprotection. Brain Res. Rev. Special Issue 482, 129-489. doi: 10.1016/j.brainresrev.2004.12.002
140. Marchetti, B., L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., and Morale, M. C. (2011). "Vulnerability to Parkinson's disease: towards an unifying theoryof disease etiology," in Encyclopedia of Environmental Health, ed J. O. Nriagu (Burlington, US: Elsevier), 5, 690-704.
141. Marchetti, B., L'Episcopo, F., Morale, M. C., Tirolo, C., Testa, N., Caniglia, S., et al. (2013). Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/b-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur. J. Neurosci. 37, 1550-1563. doi: 10.1111/ejn.12166
142. Marchetti, B., Morale, M. C., Testa, N., Tirolo, C., Caniglia, S., Amor, S., et al. (2002). Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA. Brain Res. Rev. 37, 259-272. doi: 10.1016/S0165-0173(01)00130-8
143. Marchetti, B., Serra, P. A., L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., et al. (2005b). Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: Glia as a common final pathway. Ann. N. Y. Acad. Sci. 1057, 296-318. doi: 10.1196/annals.1356.023
144. Marchetti, B., Serra, P. A., Tirolo, C., L'Episcopo,F., Caniglia, S., Gennuso, F., et al. (2005c). Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental Parkinsonism: pivotal role for glia-neuron interactions. Brain Res. Rev. 48, 302-321. doi: 10.1016/j.brainresrev.2004.12.030
145. Martino, G., Pluchino, S., Bonfanti, L., and Schwartz, M. (2011). Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol. Rev. 91, 1281-1304. doi: 10.1152/physrev.00032.2010
146. McGeer, P. L., andMcGeer, E. G. (2008). Glial reactions in Parkinson's disease.Mov Disord. 23, 474-483. doi: 10.1002/mds.21751
147. Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., et al. (2012). LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602-1611. doi: 10.1523/JNEUROSCI.5601-11.2012
148. Morale, M. C., L'Episcopo, F., Tirolo, C., Giaquinta, G., Caniglia, S., Testa, N., et al. (2008). Loss of Aromatase Cytochrome P450 function as a risk factor for Parkinson's disease? Brain Res. Rev. 57, 431-443. doi: 10.1016/j.brainresrev.2007.10.011
149. Morale, M. C., Serra, P. A., L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., et al. (2006). Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 138, 869-878. doi: 10.1016/j.neuroscience.2005.07.060
150. Morale, M. C., Serra, P., Delogu, M. R., Migheli, R., Rocchitta, G., Tirolo, C., et al. (2004). Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide. FASEB J. 18, 164-166. doi: 10.1096/fj.03-0501fje
151. More, S. V., Kumar, H., Kim, I. S., Song, S. Y., and Choi, D. K. (2013). Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediat. Inflamm. 2013:952375. doi: 10.1155/2013/952375
152. Mosimann, C., Hausmann, G., and Basler, K. (2009). Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 10, 276-286. doi: 10.1038/nrm2654
153. Mouton, P. R., Long, J. R., Lei, D. L., Howard, V., Jucker,M., Calhoiun,M. E., et al. (2002). Age and gender effects on microglia and astrocytes in brains of mice. Brain Res. N956, 30-35. doi: 10.1016/S0006-8993(02)03475-3
154. Neumann, J., Schaale, K., Farhat, K., Endermann, T., Ulmer, A. J., Ehlers, S., et al. (2010). Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 24, 4599-4612. doi: 10.1096/fj.10-160994
155. Niehrs, C. (2012). The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell. Biol. 13, 767-779. doi: 10.1038/nrm3470
156. Njie, E. G., Boelen, E., Stassen, F. R., Stassen, F. R., Steinbusch, H. W., Borchelt, D. R., et al. (2012). Ex vivo cultures of microglia from young and agent rodent brain reveal age-related changes in microglial function. Neurobiol. Aging 33, 195e1-12. doi: 10.1016/j.neurobiolaging.2010.05.008
157. Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., et al. (2017). Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy. Movem. Disord. 32, 1265-1310. doi: 10.1002/mds.27115
158. O'Keeffe, G. O., Barker, R. A., and Caldwell, M. A. (2009a). Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain. Cell Cycle 8, 2888-2894. doi: 10.4161/cc.8.18.9512
159. O'Keeffe, G. O., Tyers, P., Aarsland, D., Dalley, J. W., Barker, R. A., and Caldwell, M. A. (2009b). Dopamine induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc. Natl. Acad. Sci. U.S.A. 106, 8754-8759. doi: 10.1073/pnas.0803955106
160. Okamoto, M., Inoue, K., Iwamura, H., Terashima, K., Soya, H., Asashima, M., et al. (2011). Reduction in paracrineWnt3 factors during aging causes impaired adult neurogenesis. FASEB J. 25, 3570-3582. doi: 10.1096/fj.11-184697
161. Olanow, C. W., and Schapira, A. (2013). Therapeutic prospects for parkinson's disease. Ann Neurol. 74, 337-347. doi: 10.1002/ana.24011
162. Olanow, C. W., Shapira, A. H., and Agid, Y. (2003). Neuroprotection for Parkinson's disease: prospects and promises. Ann. Neurol. 53 (Suppl. 3), S1-S2. doi: 10.1002/ana.10566
163. Orr, C. F., Rowe,D. B.,Mizuno, Y.,Mori, H., andHalliday, G.M. (2005). A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 128, 2665-2674.
164. Ouchi, Y., Yagi, S., Yokokura, M., and Sakamoto, M. (2009). Neuroinflammation in the living brain of Parkinson's disease. Parkins. Relat. Disord. 15, S200-S204. doi: 10.1016/S1353-8020(09)70814-4
165. Peng, J., Peng, L., Stevenson, F. F., Doctrow, S. R., and Andersen, J. K. (2007). Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J. Neurosci. 27, 6914-6922. doi: 10.1523/JNEUROSCI.1569-07.2007
166. Pereira, C. P., Bachli, E. B., and Schoedon, G. (2009). The Wnt pathway:a macrophage effector molecule that triggers inflammation. Curr. Atheroscler. Rep. 11, 236-242. doi: 10.1007/s11883-009-0036-4
167. Perry, V. H., and Teeling, J. (2013). Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin. Immunopathol. 35, 601-612. doi: 10.1007/s00281-013-0382-8
168. Petit-Paitel, A., Brau, F., Cazareth, J., and Chabry, J. (2009). Involment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/Mpp+- treated neurons. PLoS ONE 4:e5491. doi: 10.1371/journal.pone.0005491
169. Phukan, S., Babu, V. S., Kannoji, A.,Hariharan, R., and Balaji, V.N. (2010). GSK3b: role in therapeutic landscape and development of modulators. Br. J. Pharmacol. 160, 1-19. doi: 10.1111/j.1476-5381.2010.00661.x
170. Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., et al. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436, 266-271. doi: 10.1038/nature03889
171. Pluchino, S.,Muzio, L., Imitola, J., Deleidi,M., Al faro-Cervello, C., Salani, G., et al. (2008). Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 131, 2564-2578. doi: 10.1093/brain/awn198
172. Ponomarev, E. D., Veremeyko, T., and Weiner, H. L. (2013). MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CN. Glia 61, 91-103. doi: 10.1002/glia.22363
173. Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., and Pitossi, F. J. (2008). Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131, 1880-1894. doi: 10.1093/brain/awn101
174. Pradhan, S., and Andreasson,. K. (2013). Commentary: progressive inflammation as a contributing factor to early development of Parkinson's disease. Exp. Neurol. 241, 148-155. doi: 10.1016/j.expneurol.2012.12.008
175. Prajapati, P., Sripada, L., Singh, K., Bhatelia, K., and Singh, R. (2015). TNF-a regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells. Biochim Biophys Acta 1852, 451-461. doi: 10.1016/j.bbadis.2014.11.019
176. Prakash, N., and Wurst, W. (2006). Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol. 575, 403-410. doi: 10.1113/jphysiol.2006.113464
177. Przedborski, S. (2010). Inflammation and Parkinson's disease pathogenesis. Mov. Disord. 25, S55-S57. doi: 10.1002/mds.22638
178. Radad, K., Moldzio, R., Al-Shraim, M., Kranner, B., Krewenka, C., and Rausch, W. D. (2017). Recent advances on the role of neurogenesis in the adult brain: therapeutic potential in Parkinson's and Alzheimer's diseases. CNS Neurol. Disord. Drug Targets 16, 740-748. doi: 10.2174/1871527316666170623094728
179. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., et al. (1998). The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395, 608-612. doi: 10.1038/26989
180. Rueger, M. A., Muesken, S., Walberer, M., Jantzen, S. U., Schnakenburg, K., Backes, H., et al. (2012). Effects of minocycline on endogenous neural stem cells after experimental stroke. Neuroscience 215, 174-183. doi: 10.1016/j.neuroscience.2012.04.036
181. Sakata, H., Niizuma, K., Yoshioka, H., Kim, G. S., Jung, J. E., Katsu, M., et al.,(2012). Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J. Neurosci. 32, 3462-3473. doi: 10.1523/JNEUROSCI.5686-11.2012
182. Salinas, P. C. (2012).Wnt signaling in the vertebrate central nervous system: from axon guidance to synaptic function. Cold Spring Harb. Perspect. Biol. 4:a008003. doi: 10.1101/cshperspect.a008003
183. Sanchez-Guajardo, V., Barnum, C. J., Tansey, M. G., and Romero-Ramos, M. (2013).Neuroimmunological processes in Parkinson's disease and their relation to a-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 5, 113-139. doi: 10.1042/AN20120066
184. Sancho, R. M., Law, B. M., and Harvey, K. (2009). Mutations in the LRRK2 Roc- COR tandemdomain link Parkinson's disease toWnt signalling pathway. Hum. Mol. Genet. 18, 3955-3968. doi: 10.1093/hmg/ddp337
185. Schaale, K., Neumann, J., Schneider, D., Ehlers, S., and Reiling, N. (2011).Wnt signaling in macrophages: augmenting and inhibiting mycobacteriainduced inflammatory responses. Eur. J. Cell Biol. 90, 553-559. doi: 10.1016/j.ejcb.2010.11.004
186. Schiess, M. (2003). Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away? Arc. Neurol. 60, 1043-1044. doi: 10.1001/archneur.60.8.1043
187. Schwartz, M., London, A., and Shecter, R. (2009). Boosting Tcell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience 158, 1133-1142. doi: 10.1016/j.neuroscience.2008.12.013
188. Seib, D. R., Corsini, N. S., Ellwanger, K., Plaas, C., Mateos, A., Pitzer, C., et al. (2013). Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 12, 204-214. doi: 10.1016/j.stem.2012. 11.010
189. Shruster, A., Ben-Zur, T., Melamed, E., and Offen, D. (2012). Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. PLoS ONE 7:e40843 doi: 10.1371/journal.pone.0040843
190. Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35. doi: 10.1007/s00401-009-0619-8
191. Soifer, H. S., Rossi, J. J., and Saetrom, P. (2007).MicroRNAs in disease and potential therapeutic applications. Mol. Ther. 15, 2070-2079. doi: 10.1038/sj.mt.6300311
192. Sonntag, K. C. (2010). MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res. 1338, 48-57. doi: 10.1016/j.brainres.2010.03.106
193. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2002).Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16, 1474-1476. doi: 10.1096/fj.02-0216fje
194. Sriram, K., Miller, D. B., and O'Callaghan, J. P. (2006). Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J. Neurochem. 96, 706-718. doi: 10.1111/j. 1471-4159.2005.03566.x
195. Staal, F. J., Luis, T. C., and Tiemessen, M. M. (2008). WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8, 581-593. doi: 10.1038/nri2360
196. Streit, W. J. (2002). Microglia as neuroprotective, immunocompetent cells of the CN. Glia 40, 133-139. doi: 10.1002/glia.10154
197. Streit, W. J. (2010). Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front. Aging Neurosci. 2:22. doi: 10.3389/fnagi.2010.00022
198. Streit, W. J., Mrak, R. E., and Griffin, W. S. (2004). Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation. 1:14. doi: 10.1186/1742-2094-1-14
199. Tansey, M. G., and Goldberg, M. S. (2010). Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510-518. doi: 10.1016/j.nbd.2009.11.004
200. Taylor, J.M.,Main, B. S., and Crack, P. J. (2013). Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease. Neurochem. Int. 62, 803-819. doi: 10.1016/j.neuint.2012.12.016
201. Teismann, P., Tieu, K., Choi, D. K., Wu, D. C., Naini, A., Hunot, S., et al. (2003). Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 100, 5473-5478. doi: 10.1073/pnas.0837397100
202. Tepavcevíc, V., Lazarini, F., Alfaro-Cervello, C., Kerninon, C., Yoshikawa, K., Garcia-Verdugo, J. M., et al. (2011). Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J. Clin. Invest. 121, 4722-4734. doi: 10.1172/JCI 59145
203. Thome, A. D., Harms, A. S., Volpicelli-Daley, L. A., and Standaert, D. G. (2016). microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J. Neurosci. 36, 2383-2390. doi: 10.1523/JNEUROSCI.3900-15.2016
204. Thored, P., Heldmann, U., Gomes-Leal, W., Gisler, R., Darsalia, V., Taneera, J., et al. (2009). Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 57, 835-849. doi: 10.1002/glia.20810
205. Toledo, E. M., Gyllborg, D., and Arenas, E. (2017). Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease. Br. J. Pharmacol. 174, 4716-4724. doi: 10.1111/bph.13871
206. van Amerongen, R. (2012). Alternative wnt pathways and receptors. Cold Spring Harb. Perspect. Biol. 4:a007914. doi: 10.1101/cshperspect.a007914
207. van Amerongen, R., Mikels, A., and Nusse, R. (2008). Alternative wnt signaling is initiated by distinct receptors. Sci. Signal. 1:re9. doi: 10.1126/scisignal.1 35re9
208. Vegeto, E., Belcredito, S., Etteri, S., Ghisletti, S., Brusadelli, A., Meda, C., et al. (2003). Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. U.S.A. 100, 9614-9619. doi: 10.1073/pnas.1531957100
209. Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., et al. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94. doi: 10.1038/nature10357
210. Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J., and Bartlett, P. F. (2012). Microglia modulate hippocampal neural precursor activity in response to exercise and aging. J. Neurosci. 32, 6435-6443. doi: 10.1523/JNEUROSCI.5925-11.2012
211. Wadhwa, M., Prabhakar, A., Ray, K., Roy, K., Kumari, P., Jha, P. K., et al. (2017). Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation. J. Neuroinflammation. 14:222. doi: 10.1186/s12974-017-0998-z
212. Wallenquist, U., Holmqvist, K., Hånell, A., Marklund, N., Hillered, L., and Fosberg-Nilsson, K. (2012). Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury. Restorative Neurol. Neurosci. 30, 9-19. doi: 10.3233/RNN-2011-0606
213. Wang, S., Chong, Z. Z., Shang, Y. C., and Maiese, K. (2012). Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. Curr. Neurovasc. Res. 9, 20-31. doi: 10.2174/156720212799297137
214. Wang, W., Yang, Y., Ying, C., Li, W., Ruan, H., Zhu, X., et al. (2007). Inhibition of glycogen synthase kinase-3b protects dopaminergic neurons from MPTP toxicity. Neuropharmacology 52, 1678-1684. doi: 10.1016/j.neuropharm.2007.03.017
215. Wang, X. J., Zhang, S., Yan, Z. Q., Zhao, Y. X., Zhou, H. Y., Wang, Y., et al. (2011). Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. Free Radic Biol. Med. 50, 1094-1106. doi: 10.1016/j.freeradbiomed.2011.01.032
216. Wei, L., Sun, C., Lei, M., Li, G., Yi, L., Luo, F., et al. (2012). Activation of Wnt/b-catenin pathway by exogenous Wnt1 protects SH-SY5Y cellsagainst 6-hydroxydopamine toxicity. J. Mol. Neurosci. 49, 105-115. doi: 10.1007/s12031-012-9900-8
217. Whitton, P. S. (2007). Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963-976. doi: 10.1038/sj.bjp.0707167
218. Whitton, P. S. (2010). Neuroinflammation and the prospects for antiinflammatory treatment of Parkinson's disease. Curr. Opin. Investig. Drugs 11, 788-794.
219. Willert, K., and Nusse, R. (2012). Wnt proteins. Cold Spring Harb. Perspect. Biol. 4:a007864. doi: 10.1101/cshperspect.a007864
220. Winner, B., and Winkler, J. (2015). Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 7:a021287. doi: 10.1101/cshperspect.a021287
221. Winner, B., Desplats, P., Hagl, C., Klucken, J., Aigner, R., Ploetz, S., et al. (2009). Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model. Exp. Neurol. 219, 543-552. doi: 10.1016/j.expneurol.2009.07.013
222. Wurst, W., and Prakash, N. (2014). Wnt-1 regulated genetic networks in midbrain dopaminergic neuron development. J. Mol. Cell Biol. 6, 34-41. doi: 10.1093/jmcb/mjt046
223. Yang, L., Tucker, D., Dong, Y., Wu, C., Lu, Y., Li, Y., et al. (2017). Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells. Exp. Neurol. 299(Pt A):86-96. doi: 10.1016/j.expneurol.2017.10.013
224. Yang, Y., Yang, L., Liang, X., and Zhu, G. (2015). MicroRNA-155 promotes atherosclerosis inflammation via targeting SOCS1. Cell Physiol. Biochem. 36, 1371-1381. doi: 10.1159/000430303
225. Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., and Yokota, C., et al. (2008). Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135, 367-375. doi: 10.1242/dev.013540
226. Zhang, J., Götz, S., Vogt Weisenhorn, D. M., Simeone, A., Wurst, W., Prakash, N., et al. (2015). A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice. Neurobiol. Dis. 82, 32-45. doi: 10.1016/j.nbd.2015.05.015
227. Zhang, J., Liu, W., Wang, Y., Zhao, S., and Chang, N. (2017). miR-135b plays a neuroprotective role by targeting GSK3b in MPP(+)-intoxicated SH-SY5Y cells. Dis. Markers 2017:5806146. doi: 10.1155/2017/5806146
228. Zhang, L., Yang, X., Yang, S., and Zhang, J. (2011). The Wnt/b-catenin signaling pathway in the adult neurogenesis. Eur. J. Neurosci. 33, 1-8. doi: 10.1111/j.1460-9568.2010.7483.x
229. Zhang, S., Wang, X. J., Tian, L. P., Pan, J., Lu, G. Q., Zhang, Y. J., et al. (2011). CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J. Neuroinflammation 8:154. doi: 10.1186/1742-2094-8-154
230. Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Blocl, M. L., et al. (2005). Aggregated alpha synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533-542. doi: 10.1096/fj.04- 2751com
231. Zhou, Y., Lu, M., Du, R. H., Qiao, C., Jiang, C. Y., Zhang, K., et al. (2016). MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Mol. Neurodegener. 11:28. doi: 10.1186/s13024-016-0094-3